Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:38 AM ET 8-K
Financial Results Clene Inc. CLNN

Clene Financial Results

Clene Inc. reported third quarter 2026 financial results, highlighting the submission of a New Drug Application (NDA) to the FDA for CNM-Au8 in ALS. The company ended the quarter with $9.9 million in cash, bolstered by a $4.0 million registered direct offering completed in September, providing a runway through mid-first quarter 2027.

“Clene’s submission of the NDA for CNM-Au8 is a pivotal achievement for the company and, more importantly, a meaningful step toward bringing new treatment options to people living with ALS. People living with ALS urgently need additional treatment options, and we appreciate the FDA’s constructive engagement throughout this process. We look forward to working closely with the Agency during its pending review. We believe CNM-Au8 has the capacity to restore and protect neuronal health and function and improve survival.”

Rob Etherington, President and CEO of Clene
8:37 AM ET 6-K
Financial Results Cenovus Energy Inc. CVE

Cenovus Energy Q3 2026 Results: Net Income $3.36B, Up 161.3% YoY

Cenovus Energy achieved record quarterly production exceeding one million BOE/d in Q3 2026, driven by record performance at Christina Lake, Foster Creek, and Sunrise. The company reported net earnings of $3.4 billion and announced a definitive agreement to acquire Athabasca Oil Corporation for $5.7 billion, expected to close in December 2026.

Key figure
Net income $3.36B · +161.3% YoY
8:37 AM ET 10-Q
Financial Results Vishay Precision Group, Inc. VPG ▶ Call

Vishay Precision Group Q3 2026 Results: Net Income $559K, Down 92.9% YoY

Vishay Precision Group reported net revenues for the third quarter of 2026 that were reduced by $2.3 million due to tariff refunds passed through to customers. The company maintains a dual-class common stock structure with approximately 12.3 million shares of Common Stock and 1.0 million shares of Class B convertible stock outstanding.

Key figure
Net income $559K · -92.9% YoY
8:37 AM ET 8-K
Financial Results Nnn REIT, Inc. NNN

Nnn REIT Financial Results

NNN REIT reported third quarter 2026 financial results with net earnings of $0.57 per diluted share and Core FFO growth of 5.9% year-over-year. The company maintained its full-year 2026 Core FFO guidance of $3.50 - $3.54 per share while reporting a high portfolio occupancy rate of 99.2%.

Term
Q3 2026

“We are pleased to report strong third quarter results, highlighted by continued healthy portfolio trends, solid investment activity, and well-timed equity capital markets execution. With $1.4 billion of available liquidity and a balance sheet built for all market cycles, we are well positioned to execute on our investment pipeline and capitalize on the opportunities that today’s market volatility may create.”

Steve Horn, Chief Executive Officer
8:36 AM ET 8-K
Financial Results Twin Disc Inc TWIN

Twin Disc Financial Results

Twin Disc reported first quarter fiscal 2027 sales of $88.7 million, a 10.9% increase year-over-year, driven by strength in the Veth product line and defense sector demand. The company achieved net income of $3.4 million and maintained a robust six-month backlog of $190.6 million.

Term
Q1 2027

“Our fiscal 2027 first quarter results built on the strong momentum we established in fiscal 2026. Demand remains healthy across our end markets, supporting record six-month backlog of $191 million in the quarter, a 7% increase from fiscal year end.”

John H. Batten, President and CEO

“We continue to prioritize investing in our growth, including the expansion of our European footprint, the continued build-out of our manufacturing capabilities in Racine, and evaluating M&A opportunities.”

John H. Batten, President and CEO
8:34 AM ET 8-K
Financial Results Marinemax Inc HZO

Marinemax Financial Results

MarineMax reported fiscal fourth quarter 2026 revenue of $520.1 million and a net loss of $13.0 million, impacted by a challenging retail environment and costs related to its pending acquisition by Safe Harbor Marinas. Despite lower boat sales, the company achieved a 270 basis point gross margin expansion to 37.4% driven by growth in higher-margin marina and service businesses.

“Fiscal 2026 demonstrated the strength of MarineMax's diversified business model and the benefits of our strategic investments to broaden our marine offerings and expand our presence in durable, higher-margin businesses.”

Brett McGill, the Company’s Chief Executive Officer and President

“Our previously announced agreement to be acquired by Safe Harbor represents an important milestone for MarineMax and reflects the value we have created by building a broader and more diversified marine business.”

Brett McGill, the Company’s Chief Executive Officer and President
8:33 AM ET 8-K
Investor Presentation Twin Disc Inc TWIN

Twin Disc Investor Presentation

Twin Disc, Inc. filed a formal investor presentation deck (Exhibit 99.1) to be used in upcoming meetings with investors and analysts starting November 4, 2026. The presentation includes non-GAAP financial measures and forward-looking statements regarding the company's strategic targets and core business performance.

8:33 AM ET 8-K
Business Update Federated Hermes, Inc. FHI

Federated Hermes Business Update

Federated Hermes, Inc. announced a proposed restructuring of its London-based subsidiary, Federated Hermes Limited, involving the elimination or transfer of approximately 200 positions. The company expects to incur $15 million in pre-tax restructuring charges through 2027 but anticipates achieving approximately $30 million in annual pre-tax cost savings upon completion.

Term
through 2027
8:29 AM ET 8-K
Financial Results Ocugen, Inc. OCGN

Ocugen Financial Results

Ocugen reported Q3 2026 financial results, highlighting a cash position of $84.6 million with an expected runway into 2028. The company advanced its gene therapy pipeline, including the initiation of the Phase 3 ArMaDa3 trial for OCU410 and receiving provisional approval for OCU400 in The Bahamas.

Term
Q3 2026

“With three Phase 3 modifier gene therapy programs underway, Ocugen is executing against a clear strategy of advancing our pipeline and leveraging strategic partnerships to expand global reach and potentially bring our therapies to patients worldwide.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen

“As we demonstrated in the third quarter, we remain focused on executing key clinical and regulatory milestones, expanding our commercial opportunities, and maintaining a disciplined approach as we advance toward the anticipated OCU400 Phase 3 topline data early next year.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen
8:23 AM ET 8-K
Financial Results Global Indemnity Group, LLC GBLI

Global Indemnity Group Financial Results

Global Indemnity Group reported Q3 2026 net income of $8.9 million ($0.61 per share) and nine-month net income of $24.2 million ($1.65 per share). New CEO Jessica E. Buss highlighted that while the third quarter was softer due to maintaining underwriting standards in a softening property market, nine-month results ran well ahead of the prior year.

“I joined GBLI as CEO this week. I studied this company closely before accepting the role, and I came in knowing exactly where we stand and what we can become. Our results for the first nine months ran well ahead of last year. The third quarter came in softer, as we held to our underwriting standards while competitors cut property rates, and we owe our shareholders a plain account of that. We also owe them a plan.”

Jessica E. Buss, CEO of Global Indemnity

“Going forward, we will hold ourselves to one measure: sustained growth in premiums, earnings and book value per share at rates far beyond anything GBLI achieved since its founding.”

Jessica E. Buss, CEO of Global Indemnity
8:17 AM ET Form 4
Insider Selling Church & Dwight Co Inc CHD

Church & Dwight Co President and CEO Richard A. Dierker Sells $9.13M of Stock

Richard A. Dierker, President and CEO, sold 83,340 shares of Church & Dwight Co Inc at $109.59 a share, worth $9.13M in total on Nov 3, 2026. Shares held after the trade: 38,659 (-68.3%).

Value
$9.13M
Shares
83,340
Price
$109.59
Role
President and CEO
Holding change
-68.3%
Trade date
Nov 3, 2026
8:17 AM ET 8-K
Capacity Expansion Terawulf Inc. WULF

Terawulf Capacity Expansion: $19B Investment

TeraWulf executed a definitive EPC agreement with Fluor for the construction of three data center buildings at its Justified Data Campus in Kentucky, supporting a $19 billion lease with Anthropic. Additionally, Google LLC entered into credit support agreements to backstop Anthropic's lease obligations, significantly strengthening the project's financing profile.

Value
$19B
Counterparty
Anthropic, PBC
Term
20 years
8:16 AM ET 8-K
Investor Presentation Septerna, Inc. SEPN

Septerna Investor Presentation

Septerna announced the selection of SEP-204 as a development candidate for Graves’ disease and thyroid eye disease, supported by preclinical data presented at the 2026 American Thyroid Association Annual Meeting. The company also filed an updated corporate presentation for use in meetings with investors and analysts.

8:16 AM ET 10-Q
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Q3 2026 Results: Net Income $48.2M, Down 5.2% YoY

Harmony Biosciences reported net product revenue of $268.9 million for the third quarter of 2026, a 12.3% increase year-over-year. Net income for the nine months ended September 30, 2026, rose to $156.1 million compared to $136.2 million in the prior year, despite higher operating expenses driven by research and development.

Key figure
Net income $48.2M · -5.2% YoY
8:12 AM ET 8-K
Reverse Stock Split Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics Reverse Stock Split

Jasper Therapeutics announced a 1-for-30 reverse stock split of its common stock, effective November 6, 2026. The split will reduce the number of outstanding shares from approximately 33.3 million to 1.1 million to increase the per-share trading price on the Nasdaq Capital Market. The authorized number of shares remains unchanged at 490 million, resulting in an increase in authorized but unissued shares available for future use.

8:11 AM ET 10-Q
Financial Results Safehold Inc. SAFE

Safehold Q3 2026 Results: Net Income $28.8M, Down 1.6% YoY

Safehold Inc. reported net income of $31.3 million for the quarter ended September 30, 2026, driven by $118.7 million in total revenues, including new hotel revenue streams. Total assets grew to $7.70 billion from $7.25 billion at year-end 2025, while the company maintained its quarterly dividend at $0.177 per share.

Key figure
Net income $28.8M · -1.6% YoY
8:11 AM ET 8-K
Executive Compensation Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Executive Compensation

Processa Pharmaceuticals appointed Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026. Mr. Flesher will receive an annual base salary of $700,000, a target bonus of up to 60%, and an initial stock option grant representing 3.0% of the company's fully-diluted capital stock, contingent on shareholder approval of a new equity incentive plan.

8:11 AM ET 10-Q
Financial Results SmartRent, Inc. SMRT

SmartRent Q3 2026 Results: Net Loss of $3.91M, Loss Narrows

SmartRent, Inc. reported total assets of $289.1 million as of September 30, 2026, a decrease from $320.9 million at year-end 2025, primarily driven by lower cash and accounts receivable balances. Total liabilities also decreased from $88.8 million to $68.7 million during the same period. The company continues to focus on its 'Vision 2028' strategic plan while managing macroeconomic headwinds and leadership changes.

Key figure
Net loss $3.91M
8:10 AM ET 8-K
Leadership Change Electronic Servitor Publication Network, Inc. XESP

Electronic Servitor Publication Network Leadership Change

Thomas Spruce resigned from his roles as Director, COO, CFO, and Secretary effective October 29, 2026. Peter Hager, the company's current President and CEO, was appointed to fill these roles on an interim basis for a 30-day term effective November 3, 2026. The resignation was not due to any disagreement with the company's operations or policies.

8:09 AM ET 8-K
Loan & Debt Carnival Corp Ltd. CCL

Carnival Corp $2B Debt Financing

Carnival Corporation established a $2.0 billion unsecured commercial paper program guaranteed by Carnival UK Ltd. The short-term notes will have maturities of up to 180 days and proceeds will be used for general corporate purposes, with the company's revolving credit facility serving as a liquidity backstop.

Value
$2B
Term
up to 180 days
8:08 AM ET 8-K
Financial Results UroGen Pharma Ltd. URGN

UroGen Pharma Financial Results

UroGen Pharma reported third-quarter 2026 financial results, highlighted by $68.0 million in ZUSDURI revenue, representing 35% sequential growth. The company also announced that the FDA has accepted its NDA for UGN-103 with a PDUFA goal date of June 14, 2027, and reported a cash position of $215.4 million.

“We delivered another strong quarter of execution, with ZUSDURI continuing to scale as growing repeat utilization, expanding community adoption, and broader physician engagement reinforce our confidence in the long-term commercial opportunity.”

Liz Barrett, President and Chief Executive Officer of UroGen

“The U.S. Food and Drug Administration’s (FDA’s) acceptance of the UGN-103 New Drug Application (NDA) in low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC), together with our newly issued patent providing coverage into July 2044, further reinforce the long-term revenue potential of our bladder cancer portfolio.”

Liz Barrett, President and Chief Executive Officer of UroGen
8:08 AM ET 8-K
Financial Results Southwest Gas Holdings, Inc. SWX

Southwest Gas Holdings Financial Results

Southwest Gas Holdings reported Q3 2026 financial results, highlighted by a return to profitability in continuing operations with net income of $12.8 million compared to a loss in the prior year. The company reaffirmed its full-year 2026 guidance and noted the completion of rate cases in Nevada and California that will increase annual revenue by approximately $80 million.

“Our strong results give us confidence that we are on track to achieve our full-year guidance. We achieved several important regulatory milestones, completing our Nevada and California rate cases, which resulted in approximately $80 million of combined annual revenue increases, reinforcing regulatory support for infrastructure investments and enhancing earnings visibility.”

Justin Brown, President and CEO of Southwest Gas Holdings
8:08 AM ET 10-Q
Financial Results Nuvectis Pharma, Inc. NVCT

Nuvectis Pharma Q3 2026 Results: Net Loss of $30.1M, Loss Widens

Nuvectis Pharma reported a significant increase in cash and cash equivalents to $140.7 million as of September 30, 2026, following a substantial equity issuance. However, the company continues to incur losses, with research and development expenses rising to $36.2 million for the first nine months of 2026 compared to $13.1 million in the prior year period.

Key figure
Net loss $30.1M
8:05 AM ET 8-K
Financial Results SmartRent, Inc. SMRT

SmartRent Financial Results

SmartRent reported Q3 2026 financial results featuring 15% total revenue growth and its fourth consecutive quarter of positive Adjusted EBITDA. The company achieved significant margin expansion, with gross margins reaching 41%, and reported that total units deployed reached nearly 942,000 as it executes its Vision 2028 Strategic Plan.

Term
Q3 2026

“SmartRent has now delivered four successive quarters of accelerating growth and margin trends as we successfully execute against our Vision 2028 Strategic Plan. The positive momentum extends across all facets of the business including our sales muscle, critical technology advancements and operations effectiveness.”

Frank Martell, President and Chief Executive Officer of SmartRent

“Total Revenue increased 15% year-over-year, with Core Revenue up 24%. As our footprint continues to scale, we are seeing expanding adoption of our Access Control and Self-Guided Tour solutions, alongside strong demand for equipment upgrades and refreshes.”

Daryl Stemm, Chief Financial Officer of SmartRent
8:04 AM ET 8-K
Leadership Change Jones Lang Lasalle Inc JLL

Jones Lang Lasalle Leadership Change

Jones Lang LaSalle (JLL) has elected Nabeel Al-Amudi and Toni Townes-Whitley as independent, non-executive members of its Board of Directors, effective December 1, 2026. Al-Amudi brings experience in global investment and infrastructure, while Townes-Whitley provides expertise in technology and regulated industries. Both will serve on the Audit & Risk and Compensation Committees through the 2027 Annual Meeting of Shareholders.

8:04 AM ET 8-K
Financial Results Avnet Inc AVT

Avnet Financial Results

Avnet reported record first quarter fiscal 2027 sales of $10.7 billion, an 82% increase year-over-year, driven by strong demand in industrial, aerospace, and AI data center applications. The company achieved record adjusted diluted EPS of $3.63 and expanded its adjusted operating income margin by 210 basis points to 4.7%.

Term
Q1 2027

“We began fiscal 2027 by delivering another record quarter, reflecting stronger demand and solid execution across all of our businesses. The fundamental backdrop for our industry remains positive, with continued growth across our core verticals such as industrial, aerospace and defense, transportation and AI and data center applications.”

Phil Gallagher, Avnet Chief Executive Officer
8:04 AM ET 8-K
Financial Results W.W. Grainger, Inc. GWW

W.W. Grainger Financial Results

W.W. Grainger reported third quarter 2026 sales of $5.2 billion, an 11.3% increase year-over-year, driven by strong performance in both High-Touch Solutions and Endless Assortment segments. The company achieved adjusted diluted EPS of $12.54 and increased its full-year 2026 earnings outlook due to consistent execution and improving demand.

Term
Q3 2026

“The third quarter performance reflects our consistent execution and an improving demand environment. As customers continue to turn to us for the products and solutions they need, both our High-Touch Solutions and Endless Assortment segments delivered impressive growth. Following another quarter of strong performance, we are increasing our 2026 guidance and remain on track for an exceptional year.”

D.G. Macpherson, Chairman and CEO
8:03 AM ET 10-Q
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Q3 2026 Results: Net Income $46.9M, Up 69.7% YoY

Trinity Capital Inc. reported a net increase in net assets resulting from operations of $121.2 million for the nine months ended September 30, 2026, compared to $96.1 million in the prior year period. Total investment income grew significantly to $275.7 million for the nine months, driven by an expanded investment portfolio which reached a fair value of $2.86 billion.

Key figure
Net income $46.9M · +69.7% YoY
8:03 AM ET 10-Q
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Q3 2026 Results: Net Income $9.8M, Down 67.3% YoY

For the nine months ended September 30, 2026, Atlanta Braves Holdings reported total revenue of $701.8 million, a 4.6% increase over the prior year, though it swung to an operating loss of $51.1 million compared to a profit in 2025. The net loss attributable to stockholders was $42.9 million, driven primarily by a significant increase in baseball operating costs and selling, general, and administrative expenses.

Key figure
Net income $9.8M · -67.3% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.